About Knight Therapeutics Canada
Canadian Specialty Pharmaceutical company improving the lives of patients.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Montreal, Quebec
- Founded
- 2014
- Company type
- Public Company
Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD. Headquartered in Montreal, Knight has over 700 employees globally.
Company locations
100 Boulevard Alexis-Nihon, Bureau 600, Montreal, Quebec H4M 2P2, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 7,824
- People linked to this company
- 27
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.